Oxygenta Pharmaceutical Ltd. - Research Center
524636 OXYGENTAPH Group (XT) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Sales | 19.94 | 14.95 | 23.01 | 37.52 | 11.85 |
| Operating profit | -5.61 | -2.54 | -0.59 | 2.07 | -0.03 |
| Interest | 0.64 | 0.35 | 0.38 | 0.54 | 0.26 |
| Gross profit | -6.25 | -2.89 | -0.97 | 1.53 | -0.28 |
| EPS (Rs) | -2.31 | -2.84 | -0.49 | 0.06 | -0.76 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Other income | - | - | - | - | 0.01 |
| Stock adjustment | -1.21 | -1.90 | 2.92 | 1.63 | -7.34 |
| Raw material | 19.76 | 12.66 | 14.49 | 28.19 | 15.22 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 0.50 | 0.43 | 0.15 | 0.18 | 0.31 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 6.49 | 6.31 | 6.05 | 5.45 | 3.69 |
| Provisions made | - | - | - | - | - |
| Depreciation | 1.33 | 0.80 | 0.79 | 0.81 | 0.50 |
| Taxation | -0.02 | - | 0.12 | - | - |
| Net profit / loss | -7.72 | -4.03 | -0.70 | 0.09 | -0.78 |
| Extra ordinary item | -0.16 | -0.34 | 1.18 | -0.64 | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 33.48 | 14.20 | 14.20 | 14.20 | 10.20 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | -28.14 | -17.02 | -2.58 | 5.52 | -0.28 |
| GPM (%) | -31.32 | - | -4.23 | 4.08 | -2.35 |
| NPM (%) | -38.71 | - | -3.03 | 0.23 | -6.57 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis